Case Reports in Gastrointestinal Medicine [8] P. M. Glauser, P. Wermuth, G. Cathomas, E. Kuhnt, S. A. Ka¨ser, and C. A. Maurer, “Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results,” World Journal of Surgery, vol. 35, no. 11, pp. 2549–2554, 2011. [9] B. T. Green and D. A. Tendler, “Ischemic colitis: a clinical review,” Southern Medical Journal, vol. 98, no. 2, pp. 217–222, 2005. [10] F. M. Moses, “Exercise-associated intestinal ischemia,” Current Sports Medicine Reports, vol. 4, no. 2, pp. 91–95, 2005. [11] A. Alaranta, H. Alaranta, and I. Helenius, “Use of prescription drugs in athletes,” Sports Medicine, vol. 38, no. 6, pp. 449–463, 2008. [12] M. Ciocca, “Medication and supplement use by athletes,” Clinics in Sports Medicine, vol. 24, no. 3, pp. 719–738, 2005. [13] C. Tsitsimpikou, A. Tsiokanos, K. Tsarouhas et al., “Medi- cation use by athletes at the Athens 2004 summer olympic games,” Clinical Journal of Sport Medicine, vol. 19, no. 1, pp. 33–38, 2009. [14] P. Tscholl, A. Junge, and J. Dvorak, “The use of medication and nutritional supplements during FIFA world cups 2002 and 2006,” British Journal of Sports Medicine, vol. 42, no. 9, pp. 725–730, 2008. [15] P. C. Wharam, D. B. Speedy, T. D. Noakes, J. M. D. Thompson, S. A. Reid, and L. M. Holtzhausen, “NSAID use increases the risk of developing hyponatremia during an ironman tri- athlon,” Medicine and Science in Sports and Exercise, vol. 38, no. 4, pp. 618–622, 2006. [16] M. Stolte, D. Karimi, M. Vieth et al., “Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inﬂam- matory drug-induced lesions,” World Journal of Gastroenterol- ogy, vol. 11, no. 37, pp. 5828–5833, 2005. 3